Estimation of the usefulness of neoplastic markers TPS and CA 125 in diagnosis and monitoring of ovarian cancer

European Journal of Gynaecological Oncology

Volumn 20, Issue 4, 1999, Pages 298-301

  Zygmunt, Andrzej ^b   Madry, R ^a   Markowska, J ^a   Fischer, Z ^c  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^b Dept of Obstetrics and Gynecology   (Poland)

^c NONE

Author keywords

Monitoring of therapy; Ovarian cancer; TPS

Indexed keywords

CA 125 ANTIGEN; TISSUE POLYPEPTIDE ANTIGEN; TUMOR MARKER;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CHEMOTHERAPY; CLINICAL ARTICLE; DIAGNOSTIC ACCURACY; DISEASE COURSE; FEMALE; HUMAN; HUMAN TISSUE; MUCINOUS CARCINOMA; OVARY CANCER; PATIENT MONITORING;

ADULT; AGED; CA-125 ANTIGEN; CARCINOMA; DISEASE PROGRESSION; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM STAGING; OVARIAN NEOPLASMS; PEPTIDES; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 0033491676     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Zatoński W., Tyczyński J.: "Malignant tumors in Poland in 1993" (in Polish). Wydawnictwo Centrum Onkologii, Inst. im. M. Skłodowskiej-Curie, Warszawa 1996.
2. Jacobs J., Prys Davies A., Oram D.: "Role of CA125 in screening for ovarian cancer". In: "Ovarian Cancer 2", Biology, Diagnosis and Management, Chapman and Hall Medical, 1990.
3. Markowska J.: "Suitability of CA125 estimates for diagnosis and monitoring of ovarian cancer" (in Polish). Kliniczna Perinatologia i Ginekologia, 1992, 3, 113.
4. Selveda P., Rosen A., Denison U.: "Is CA125 monitoring useful in patients with epithelial ovarian carcinoma and preoperative negative CA125 serum levels". Gynecol. Oncol., 1991, 43, 154.
5. Teneriello M. G., Park R. C.: "Early detection of ovarian cancer". CA Cancer J. Clin., 1995, 45, 71.
6. Zanaboni F., Vargadoro F., Piesti M. et al.: "Tumor antigen CA125 as a marker of ovarian epithelial carcinoma". Gynec. Oncol., 1987, 28, 61.
7. Björklund D. B.: "Biochemical basis for tumor markers with special reference to TPS". Symposium "Three Years with the proliferation marker TPS", Barcelona, February 4-6, 1993. Publication from Beki Diagnostics AB.
8. Inoba N., Fukasawa J., Okayima Y. et al.: "Immunoradiometrical measurement of tissue polypeptide specific antigen (TPS) in normal healthy, nonpregnant and pregnant Japanese women". Asia-Oceania J. Obstet. Gynaecol., 1993, 19 (4), 459.
9. Salman T., El-Ahmady O., Sawsan M. R., Nahed M. H.: "The clinical value of serum TPS in gynecological malignancies". Int. J. Biol. Markers, 1995, 10, 81.
10. Canney P. A., Moore M., Wilkinson P. M., Whitehead M.: "Ovarian cancer antigen CA125. A prospective clinical assessment of its role as a tumour marker". Br. J. Cancer, 1984, 50, 765.
11. Zurawski V. R., Knapp R. C., Einborn N. et al.: "An initial analysis of preoperative serum CA125 levels in patients with early stage ovarian carcinoma". Gynecol. Oncol., 1988, 30, 7.
12. Halim A. B., El-Ahmady O., El-Sokkary F., Motawi T.: "How can you choose a biological marker panel for gynecological cancer". The Cancer Journal, 1993, 4, 201.
13. Caffier H.: "TPS beim Ovarialcarzinom". Symposium "Zwei Jahre TPS-Assay". Hermann Biermann GmbH, Juni 1992.
14. Patsner B., Mann W. J.: "The value of preoperative serum CA125 levels in patients with a pelvic mass". Am. J. Obstet. Gynecol., 1988, 159, 873.
15. Shobana A., Onsrud M.: "Tissue polypeptide specific antigen and CA125 as serum tumor markers in ovarian carcinoma". Tumor Biol., 1994, 15, 361.
16. Sliutz G., Tempfer C., Kainz C. et al.: "Tissue polypeptide specific antigen and cancer associated serum antigen in the follow-up of ovarian cancer". Anticancer Res., 1995, 15, 1127.
17. Selveda P., Schemper M., Spona J.: "CA125 as an independent prognostic factor for survival in patients with epithelial ovarian cancer". Am. J. Obstet. Gynecol., 1989, 161, 1213.
18. Dörffler P., Caffier H.: "Comparison of the clinical value of tumor marker TPS and CA125 regarding ovary carcinomas". In R. Klapder (Ed.): "Tumor Associated Antigens, Oncogens, Receptors, Cytokines in Tumor Diagnosis and Therapy at the Beginning of the Nineties". W. Zuckschwerdt Verlag, München, 1992.
19. Enguidanos M. J., Rodriguez M., Alsa A. et al.: "Serum levels of CA19-9, CA125, CEA and TPS in the follow-up of patients with ovarian carcinoma". Symposium "Three Years with the proliferation marker TPS". Barcelona, February 4-6, 1993. Publication from Beki Diagnostics AB.
20. Dörffler P., Caffier H.: "TPS as tumor marker and prognostic indicator in ovarian cancer". J. Tumor Marker Oncol., 1992, 7, 89.